ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,164.05
14.9 (1.3%)
BSENSE

Oct 09

BSE+NSE Vol: 74.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryERIS Lifescience VS Pharmaceuticals & Biotechnology
 
1D
1.3%
1.23%
1W
-2.17%
0.78%
1M
-12.83%
-3.07%
YTD
-22.59%
-14.96%
1Y
-26.81%
-11.8%
3Y
32.25%
10.62%
5Y
48.31%
20.67%
10Y
%
158.27%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.62%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.68%
0%
-18.68%
6 Months
-14.59%
0.52%
-14.07%
1 Year
-26.81%
0.45%
-26.36%
2 Years
-18.3%
1.09%
-17.21%
3 Years
32.25%
1.76%
34.01%
4 Years
60.59%
1.98%
62.57%
5 Years
48.31%
2.70%
51.01%

Latest dividend: 7.21 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-2.46%
4
Quartile
quartile-4
Jun-Sep
-16.98%
3
Quartile
quartile-3
Mar-Jun
10.73%
3
Quartile
quartile-3
YTD
-26.81%
1
Quartile
quartile-1
2025
9.85%
3
Quartile
quartile-3
2024
50.33%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-2.46%
4
Quartile
quartile-4
Jun-Sep
-16.98%
4
Quartile
quartile-4
Mar-Jun
10.73%
4
Quartile
quartile-4
YTD
-26.81%
1
Quartile
quartile-1
2025
9.85%
2
Quartile
quartile-2
2024
50.33%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-2.46%
4
Quartile
quartile-4
Jun-Sep
-16.98%
4
Quartile
quartile-4
Mar-Jun
10.73%
3
Quartile
quartile-3
YTD
-26.81%
2
Quartile
quartile-2
2025
9.85%
2
Quartile
quartile-2
2024
50.33%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available